How is NoMA preparing for the new Regulation?https://legemiddelverket.no/english/clinical-trials/new-clinical-trials-regulation/how-is-noma-preparing-for-the-new-regulationHow is NoMA preparing for the new Regulation?3005
Clinical Trials Information System (CTIS)https://legemiddelverket.no/english/clinical-trials/new-clinical-trials-regulation/clinical-trials-information-system-ctisClinical Trials Information System (CTIS)Information regarding the Training Program for the Clinical Trials Information System (CTIS) in relation to the implementation of the new Clinical Trial Regulation (Regulation (EU) No 536/2014)2887Information regarding the CTIS in relation to the implementation of the new Clinical Trial Regulation (Regulation (EU) No 536/2014)
Information regarding the new Clinical Trials Regulationhttps://legemiddelverket.no/english/clinical-trials/new-clinical-trials-regulation/information-regarding-the-new-clinical-trials-regulationInformation regarding the new Clinical Trials RegulationFrom the 31st of January 2022, clinical trials conducted in the EU will be regulated under a new regulatory framework, the EU Clinical Trials Regulation no. 536/2014.3000From the 31st of January 2022, clinical trials conducted in the EU will be regulated under a new regulatory framework, the EU Clinical Trials Regulation no. 536/2014.
Transition period and guidelineshttps://legemiddelverket.no/english/clinical-trials/new-clinical-trials-regulation/transition-period-and-guidelinesTransition period and guidelinesThere will be a transition period for up to one year after the regulation has come into force.3002There will be a transition period for up to one year after the regulation has come into force.

​Fant du det du lette etter?